ARCHIVES

Guest Editorial: The Academic Difference: George Weiner On How America’s Cancer Centers Are More Valuable Than Ever

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Cancer, AIDS Drug Screening Contracts Ok’d For Recompetition

February 28, 1992

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

NCI awards $7.3 Million for Studies In Cancer communications

October 15, 1993

NCI Details How Year 2000 Goals Can Be Reached Bypass Budget Spells Out How Much It Will Cost

June 8, 1984

Conferees Set $1.991 Bil. NCI Budget, Ax Earmark For Breast Cancer, But Find $210 Mil. In Defense

October 9, 1992

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001